Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Is Progression-Free Survival without Overall Survival Benefit Enough?

By Beacon Medical Interchange FEATURING Jack West

0 views

October 29, 2018

Dr. Jack West discusses results and the significance of two important Japanese trials that test ...
read more ↘ the combination of erlotinib (Tarceva) with bevacizumab (Avastin), which shows a consistent improvement in progression-free survival but not overall survival.
↖ read less

Comments 0